Raj Davé is a partner in the law firm's Intellectual Property practice and is located in the Northern Virginia office. He focuses on intellectual property counseling, patent prosecution, dispute resolution, licensing, technology transactions, intellectual property mining and enforcement, reexamination and reissue practice, pre-litigation opinions and patent litigation. He has formed strategic alliances with major investment groups to finance patent litigations.
He is the Co-Leader of Global Pharma and has assembled a highly experienced team of experts from a cross-section of key practice areas, including FDA/regulatory, intellectual property, litigation, technology transactions, and trade secrets. He represents many generic pharmaceutical companies in ANDA challenges in court and through Inter Partes Review at the US Patent Office.
His clients include start-ups to major corporations. He has extensive experience in several diversified technologies, including biotechnology, business method, chemical, electrical, hardware and software technologies, information technology and internet, materials and polymer science, pharmaceuticals and telecommunication.
He has published articles in Duke Law & Technology Review, Yale Journal of Law and Technology, and Harvard Journal of Law and Technology, among others.
He is recognized an “IP Star” by Managing Intellectual Property and Legal 500 US. He has received numerous awards including Burton Award for Legal Achievement (2004), Robert C. Watson Award of the American Intellectual Property Law Association (2003), Judge John R. Brown Award for Excellence in Legal Writing (2003), Finnegan Prize of The George Washington University Law School, First Place (2003), and Nathan Burkan Memorial Competition, American Society of Composers, Authors and Publishers (ASCAP), National Prize (1997).
He is on the Board of Invent Now (parent of Inventors Hall of Fame) and other non-profit organizations.
He is a member of the core drafting team of The Sedona Conference® Working Group 10 (Patent Litigation Best Practices) and currently serves on the Working Group 10 Steering Committee.
IP Licensing in Nanotechnology, AIPLA 2012 Annual Meeting, October 2012
Managing Intellectual Property Portfolio in the U.S. and India, 3rd Summit for US-India Trade & Economics (SUITE), May 2012
Managing Your Intellectual Property Portfolio in the U.S. and India, USINDIA Business Council (USIBC), April 2009
Intellectual Property in India, 2008 NYIPLA Annual Conference, January 2008
Inherent Anticipation: Lingering "Side Effects" on the Pharmaceutical Industry, 2007 AIPLA Annual Conference, October 2007
Declaratory Judgment Standard Post-MedImmume, 2007 AIPLA Annual Conference, October 2007
Compulsory Licensing in the United States, China, Japan, Germany and India, 1st IPO-JOP Asian Practice International Congress, September 2005
Unforeseeability - The Touchstone of the Doctrine of Equivalents in the United States, 2004 AIPLA Annual Conference, October 2004